CUSI MARIA GRAZIA

Maria Grazia
Cusi
Dipartimento di Biotecnologie Mediche
Professore Ordinario

Contacts

mariagrazia.cusi@unisi.it
0577232811 [int.2811],0577233851 [int.3851] (Accettazione Lab Microbiologia e Virologia)

Curriculum Vitae

cv

Teaching activities

Completion accademic year: 2025/2026

INTERNSHIP MEDICAL MICROBIOLOGY
Course year: 2 Full cicle (6 years) MEDICINA E CHIRURGIA A.Y. 2024/2025
MICROBIOLOGY AND CLINICAL MICROBIOLOGY
Course year: 3 Full cicle (6 years) MEDICINA E CHIRURGIA A.Y. 2023/2024
VIRAL BIOTECHNOLOGIES IN CANCER AND INFECTION
Course year: 1 Second cycle degree (Laurea Magistrale) MEDICAL BIOTECHNOLOGIES A.Y. 2025/2026
VIROLOGICAL, SEROLOGICAL TECHNIQUES AND DIAGNOSTIC APPLICATIONS
Course year: 2 First cycle degree (DM 270) BIOMEDICAL LABORATORY TECHNIQUES A.Y. 2024/2025
VIROLOGY
Course year: 1 First cycle degree (DM 270) BIOMEDICAL LABORATORY TECHNIQUES A.Y. 2025/2026
VIROLOGY
Course year: 2 First cycle degree (DM 270) BIOTECNOLOGIE A.Y. 2024/2025
VIROLOGY AND PARASSITOLOGY
Course year: 2 Full cicle (6 years) MEDICINA E CHIRURGIA A.Y. 2024/2025

Completion accademic year: 2024/2025

INTERNSHIP MEDICAL MICROBIOLOGY
Course year: 2 Full cicle (6 years) MEDICINA E CHIRURGIA A.Y. 2023/2024
MICROBIOLOGY AND CLINICAL MICROBIOLOGY
Course year: 3 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2022/2023
VIROLOGY
Course year: 1 First cycle degree (DM 270) BIOMEDICAL LABORATORY TECHNIQUES A.Y. 2024/2025

Registration for exams

Research

Ultime pubblicazioni:

  • Beligni, G., Alessandri, G., Cusi, M.G. (2025). Genotypic Characterization of Human Parvovirus B19 Circulating in the 2024 Outbreak in Tuscany, Italy. PATHOGENS, 14(2) [10.3390/pathogens14020121]. - view more
  • Beligni, G., Bartalini, S., Cusi, M.G. (2024). Detection of RSV Genome in Cerebrospinal Fluid of a Patient with Guillain Barrè Syndrome: A Case Report. ANNALS OF CASE REPORTS, 9(1965) [10.29011/2574-7754.101695]. - view more
  • Paciello, I., Maccari, G., Pierleoni, G., Perrone, F., Realini, G., Troisi, M., et al. (2024). SARS-CoV-2 JN.1 variant evasion of IGHV3-53/3-66 B cell germlines. SCIENCE IMMUNOLOGY, 9(98) [10.1126/sciimmunol.adp9279]. - view more
  • Gori Savellini, G., Anichini, G., Manetti, F., Trivisani, C.I., Cusi, M.G. (2024). Deletion of 82–85 N-Terminal Residues in SARS-CoV-2 Nsp1 Restricts Virus Replication. VIRUSES, 16(5) [10.3390/v16050689]. - view more
  • Lazzeri, C., Grossi, P.A., Procissi, A.P.o., Rossolini, G.M., Cusi, M.G., Pane, P.L., et al. (2024). Low seroprevalence of anti‐human T‐cell leukemia virus‐I/II antibodies among brain‐dead donors in Tuscany—An 8‐year observational study. TRANSPLANT INFECTIOUS DISEASE, 26(3) [10.1111/tid.14293]. - view more
All publications